Bicyclic fibrinogen antagonists

Details Bicyclic fibrinogen antagonists Bicyclic fibrinogen antagonists

1995-05-22

1997-02-11

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546141, C07D21724, A61K 3147

Patent

active

056021453

ABSTRACT:
This invention relates to compounds of the formula: ##STR1## which are effective for inhibiting platelet aggregation, pharmaceutical compositions for effecting such activity, and a method for inhibiting platelet aggregation.

REFERENCES:
patent: 5116985 (1992-05-01), Takeshita
patent: 5260316 (1993-11-01), Van Duzer et al.
patent: 5338851 (1994-08-01), Huff et al.
Banner, Perspect. Med. Chem., pp. 27-43, 1993.
Shuman, J. Med. Chem., vol. 36, pp. 314-319, 1993.
Thrombosis and Haemostasis, vol. 70(1), pp. 94-98 (1993), Topol et al.
Coronary Artery Disease, vol. 3, No. 11, pp. 1016-1029 (1992), Coller.
J. of Pharmacology and Experimental Therapeutics, vol. 270, No. 2, pp. 614-621 (1994), Nichols.
TIPS, vol. 13, pp. 413-417 (1992), Nichols et al.
Chemical Abstracts, vol. 93, No. 5, p. 910 (1980).
Chemical Abstracts, vol. 76, No. 1, pp. 3667-3668 (1972).

Affiliated with

Also associated with

Rating

Bicyclic fibrinogen antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic fibrinogen antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic fibrinogen antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342421